Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nintedanib”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1
Not applicableNo Longer AvailableNCT05624281
What this trial is testing

A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)

Who this might be right for
Lung Diseases, Interstitial (in Pediatric Populations)Childhood Interstitial Lung Disease (chILD)
Boehringer Ingelheim
Testing effectiveness (Phase 2)Looking for participantsNCT04976036
What this trial is testing

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Dr. Romain Lazor 48
Large-scale testing (Phase 3)Ended earlyNCT01907100
What this trial is testing

Nintedanib (BIBF 1120) in Mesothelioma

Who this might be right for
Mesothelioma
Boehringer Ingelheim 545
Not applicableWithdrawnNCT05676112
What this trial is testing

Safety of Nintedanib in Real World in China

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim
Early research (Phase 1)Not Yet RecruitingNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Testing effectiveness (Phase 2)Study completedNCT04046614
What this trial is testing

Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology

Who this might be right for
Adenocarcinoma of the Lung
AIO-Studien-gGmbH 56
Testing effectiveness (Phase 2)Looking for participantsNCT06071013
What this trial is testing

Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung CancerEGFR Gene MutationEGFR-TKI Resistant Mutation
China Medical University Hospital 20
Large-scale testing (Phase 3)Study completedNCT03283007
What this trial is testing

Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2

Who this might be right for
Lung-transplant Recipients
Assistance Publique - Hôpitaux de Paris 58
Testing effectiveness (Phase 2)Study completedNCT01170065
What this trial is testing

Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 198
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Large-scale testing (Phase 3)Study completedNCT02999178
What this trial is testing

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 663
Post-approval studies (Phase 4)Looking for participantsNCT06479603
What this trial is testing

RCT of Nintedanib in Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
Post Graduate Institute of Medical Education and Research, Chandigarh 120
Testing effectiveness (Phase 2)Study completedNCT00801294
What this trial is testing

A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07162961
What this trial is testing

Nintedanib for Improving Reproductive Outcomes in Adenomyosis

Who this might be right for
Adenomyosis of Uterus
Sun Yat-sen University 328
Not applicableStudy completedNCT03047031
What this trial is testing

Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 21
Not applicableApproved For MarketingNCT03843892
What this trial is testing

An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Not applicableStudy completedNCT04702893
What this trial is testing

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 108
Not applicableNot Yet RecruitingNCT07404423
What this trial is testing

OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Modena and Reggio Emilia 1,000
Large-scale testing (Phase 3)Study completedNCT04093024
What this trial is testing

Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 39
Load More Results